Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: News
News
News Search  
Nicastrin—A DAPper Role in γ-Secretase
18 August 2005. Though we've known for some time now that the protein nicastrin is a major player in the γ-secretase complex (see ARF related news story), its exact role has remained somewhat elusive. But in last Friday's Cell, Gang Yu, Thomas Sudhof, and colleagues at the University of Texas Southwestern Medical Center, Dallas, report quite a dapper role for nicastrin—it introduces Notch and the Aβ precursor protein (AβPP) to the presenilins and it does so by virtue of its DAP domain. The finding not only helps resolve the burning question of how γ-secretase recognizes its substrates, but it could also open up new therapeutic strategies for preventing production of amyloid-β (Aβ).

Yu had previously shown that nicastrin can bind to γ-secretase substrates (see Yu et al., 2000). To get a better picture of how this happens, first author Sanjiv Shah and colleagues focused on various parts of the transmembrane protein. Using immunoprecipitation experiments, they found that the N-terminal part of nicastrin interacts with C99, the γ-secretase substrate that remains after AβPP's ectodomain is shed through β-secretase cleavage. More specifically, Shah and colleagues found that it is nicastrin's ectodomain that binds to C99 and also to N100, the analogous piece of the signaling molecule Notch.

Shah and colleagues next focused on a portion of nicastrin's ectodomain, the DAP domain, so called because it harbors two highly conserved motifs—a DYIGS amino acid sequence found in nicastrin and its orthologs and a peptidase homologous region. The authors found that a 28-amino-acid region in this DAP domain is needed for γ-secretase activity. Using nicastrin mutants, they also found that one specific amino acid, glutamate 333 (E333), is essential for activity. Replacing this with alanine, arginine, serine, or another dissimilar amino acid abolished activity, whereas conservative replacement with an aspartate had little effect.

Of course, there are many ways to inhibit γ-secretase activity, one being to prevent formation of the core complex, which comprises presenilin (1 or 2), Aph1, Pen2, and nicastrin. However, Shah and colleagues found that while mutating the transmembrane region of nicastrin abolished endoproteolysis of presenilin, a prerequisite for maturity of the complex, E333A mutations had no effect on complex maturation. The results suggest that the DAP domain is not involved in the formation of the complex, but is required for the complex to function, once formed. "These data agree with a model in which assembly of nicastrin, APH-1, presenilin, and PEN-2 precedes presenilin endoproteolysis, which subsequently is required for activation of γ-secretase activity to cleave type I membrane proteins. Moreover, these results provide compelling evidence that [the] nicastrin DAP domain plays a direct functional role in γ-secretase-substrate recognition," write the authors. In support of this, they found that a short peptide that mimics the γ-secretase cleavage site is not cleaved by recombinant γ-secretase made using nicastrin mutated in the transmembrane domain, which fits with the essential role of this region in complex assembly. In contrast, recombinant secretase made with the E333A mutant of nicastrin did cleave the peptide mimic, bolstering the idea that the ectodomain of nicastrin is involved in recognizing larger γ-secretase substrates (see figure).

Nicastrin’s Role Recognized
The authors propose a model for regulated intramembrane cleavage (RIP) whereby after ectodomain shedding (2), nicastrin recognizes the remaining stubs on the outer surface of the membrane (3) and then docks them with the catalytic core of γ-secretase (4), setting up the substrates for cleavage (5). [Image courtesy of Cell Press]

While these results shed more light on the role of nicastrin and the functioning of γ secretase, they also might lead to novel therapeutics. Shah and colleagues found, for example, that a free amino terminus is a prerequisite for cleavage by γ-secretase. When the authors blocked the N-terminal of C99 with an antibody, proteolysis was prevented. While an antibody obviously adds considerable bulk to the N-terminus of C99, the much smaller biotin and fluorescein moieties also blocked cleavage when attached to the N-terminus, raising the possibility that small molecules that bind to the extracellular head of C99 could prevent formation of Aβ.—Tom Fagan.

Reference:
Shah S, Lee S-F, Tabuchi K, Hao Y-H, Yu C, LaPlant Q, Hall H, Dann III CE, Sudhof T, Yu G. Nicastrin functions as a γ-secretase-substrate receptor. Cell. 2005;122:1435-447. Abstract

 
Comments on News and Primary Papers
  Comment by:  Michael Wolfe, ARF Advisor
Submitted 19 August 2005  |  Permalink Posted 19 August 2005

This is an excellent study from the lab of Gang Yu, the original discoverer of nicastrin as a presenilin partner needed for γ-secretase activity when he was with Peter St. George-Hyslop in Toronto. In his new lab at UT Southwestern, Yu has nailed down an essential role for nicastrin in substrate recognition. To date, virtually nothing has been known about the specific biochemical role of nicastrin in γ-secretase activity. Nicastrin (NCT) is needed for assembly and maturation of the protease complex, including presenilin endoproteolysis into N-terminal fragment (NTF) and C-terminal fragment (CTF) subunits, and the NCT transmembrane domain is critical for these events. However, all the action (substrate binding and catalysis) has so far appeared to be taking place on presenilin. Recent work from our lab (Kornilova et al., 2005) located a substrate docking site at the interface between the two presenilin subunits, at a site distinct from the active site, which is also located at the NTF/CTF interface. The implication is that substrate...  Read more

  Comment by:  Bart De Strooper, ARF Advisor
Submitted 22 August 2005  |  Permalink Posted 23 August 2005

This is an excellent paper.

View all comments by Bart De Strooper

  Comment by:  Vincent Marchesi, ARF Advisor
Submitted 22 August 2005  |  Permalink Posted 23 August 2005

The strength of this paper is the imaginative use of carefully crafted recombinant peptides to study a complicated process that is difficult to approach using conventional cell biological techniques. But one also has to keep in mind that no "native" molecules are actually studied under in vivo conditions. Recombinant C99 peptides are often studied as a more accessible form of the amyloid-β precursor protein (AβPP), the physiological substrate of γ-secretase, and when they are expressed in living cells, one can be reasonably confident that they are mimicking the endogenous molecules. But a consideration in this study is whether they also behave the same way in detergent extracts. Following cleavage by β-secretases, the natural C99 peptides are likely to be dimers in situ, possibly sequestered in lipid raft-like domains, and still attached to an elaborate cytoskeletal network in the adjacent cytoplasm. We have no idea how recombinant-derived peptides are arranged in detergent extracts. If they exist as small micelles, as is likely, are they sticky? Do they bind other proteins that...  Read more

  Primary Papers: Nicastrin functions as a gamma-secretase-substrate receptor.

Comment by:  Tommaso Russo, ARF Advisor
Submitted 23 August 2005  |  Permalink Posted 23 August 2005
  I recommend this paper

  Comment by:  Stefan Lichtenthaler
Submitted 24 August 2005  |  Permalink Posted 24 August 2005

It has been known for a while that the ectodomain of type I membrane proteins needs to be proteolytically trimmed before the proteins can be further processed by γ-secretase. This led to the speculation that γ-secretase—and more specifically, the nicastrin subunit within the complex—must somehow be able to act as a molecular ruler and measure the length of the ectodomain of the γ-secretase substrates. Just how this can happen remained unclear. The elegant and convincing work by Shah and colleagues shows that, in fact, nicastrin can act as the molecular ruler. Their appealing model proposes that nicastrin sticks out of the membrane like a crane, binds the substrate, and shifts it to its docking or processing site in the γ-secretase complex. The free N-terminus of a substrate protein seems to be the primary determinant for recognition. Thus, nicastrin should be able to bind substrates regardless of their primary sequence—as long as they have a short ectodomain and contain a transmembrane domain. This model fits well with previous data by us and others, showing that γ-secretase has...  Read more

  Primary Papers: Nicastrin functions as a gamma-secretase-substrate receptor.

Comment by:  Rachael Neve
Submitted 25 August 2005  |  Permalink Posted 29 August 2005
  I recommend this paper

  Comment by:  Jacob Mack
Submitted 19 August 2005  |  Permalink Posted 30 August 2005

I find this article very informative, however, it is merely educational. While I find it interesting, it is not by finding every molecular binding site and protein involved in AD pathogenesis that we will get us closer to a cure. I love molecular and cellular mechanisms of life... in the words of the great pilot D.P. Davies: "let's get on with it."

View all comments by Jacob Mack

  Comment by:  Prakriti Sehgal
Submitted 13 March 2013  |  Permalink Posted 15 March 2013

Excellent, and a very useful study by Yu et al. The article has proved to be quite informative to me, and I am sure will assist me in my research work. Thank you for this commendable work.

View all comments by Prakriti Sehgal
  Submit a Comment on this News Article
Cast your vote and/or make a comment on this news article. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Country or Territory:
*Login Email Address  
*Password    Minimum of 8 characters
*Confirm Password  
Stay signed in?  

I recommend the Primary Papers

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:


*Enter the verification code you see in the picture below:


This helps Alzforum prevent automated registrations.

Terms and Conditions of Use:Printable Version

By clicking on the 'I accept' below, you are agreeing to the Terms and Conditions of Use above.
Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
ADNI Related Links
ADNI Data at LONI
ADNI Information
DIAN
Foundation for the NIH
AddNeuroMed
neuGRID
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad